they are piling on and will continue. The price will suffer for a while longer. Leo is doing the right thing. Unfortunately this will be an overhang on CTIX price for some time. This could make partnerships more difficult. A deep pockets pharma will be hesitant to get in bed with a small biotech with pending class actions. Ultimately the science will win out.